doxorubicin- N- (2- hydroxypropyl)methacrylamide galactosamine conjugate

a polymeric anticancer conjugate composed of an N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer backbone and pendant doxorubicin (DOX) linked via a Gly-Phe-Leu-Gly peptide spacer, additionally galactose residues are present to facilitate liver targeting; structure in first source

Also Known As:

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results